AYTU BIOPHARMA, INC Stock Split Ratio
AYTU BIOPHARMA, INC (AYTU) had Stock Split Ratio of 5.00% as of 2023-01-06, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-11-14
- 2023-01-06: Stockholders' Equity Note, Stock Split, Conversion Ratio 5.00%.
- 2015-06-08: Stockholders' Equity Note, Stock Split, Conversion Ratio 1217.40%; Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 1217.40%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month |
|---|---|---|
| 2023-01-06 | 5.00% 10-Q · filed 2023-11-14 | |
| 2015-06-08 | 1217.40% 10-Q · filed 2015-11-06 | 1217.40% 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |